Dr. Corinne E. Bott-Silverman, MD

Dr. Bott-Silverman practices at The Cleveland Clinic Florida - HOPD in West Palm Beach, Florida.

Dr. Bott-Silverman's NPI, 1164485116, was assigned on April 10, 2006. Dr. Bott-Silverman graduated from Saint Louis University School Of Medicine in 1979. Dr. Bott-Silverman's Ohio license number on file is 35051833B.

Dr. Bott-Silverman's primary practice is The Cleveland Clinic Florida - HOPD, at 525 Okeechobee Blvd, West Palm Beach, FL 33401.

Dr. Bott-Silverman's primary practice is The Cleveland Clinic Florida - HOPD in West Palm Beach, Florida. Dr. Bott-Silverman is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic Florida. Dr. Bott-Silverman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bott-Silverman practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bott-Silverman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bott-Silverman is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bott-Silverman's licenses on file in 3 states: Ohio, Maine and Florida.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart blockage, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Bott-Silverman treats.

CMS data shows 182 Medicare services from Dr. Bott-Silverman across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $21,371 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Bott-Silverman in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bott-Silverman's median patient age at 69, with 53% women.

In 2024, Dr. Bott-Silverman wrote 493 Medicare Part D claims for 75 patients. 61% of them were for generic drugs. CMS names the drug for 372 of them, across 12 drugs with 11 or more claims each, at $453,936 in total drug cost. In 2023, CMS named 227 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Bott-Silverman for performance year 2024, reported through an alternative payment model (APM). Dr. Bott-Silverman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bott-Silverman as offering telehealth.

Dmand AI links 31 papers to Dr. Bott-Silverman, published from 2015 to 2023. The most frequent topics are Heart Transplantation, Coronary Vessels and Ultrasonography, Interventional. Dr. Bott-Silverman has published most often in Am J Cardiol. Dr. Bott-Silverman's most frequent co-authors are Mohamad Hilal Yamani, MD, Ashraf Sami Abdo, MD and Jose L. Navia, ND.

CMS Open Payments shows 1 general payment to Dr. Bott-Silverman from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $22.

Dmand AI lists 2 awards for Dr. Bott-Silverman, most recently CMS Stage 1 EHR in 2013.

Dr. Bott-Silverman graduated from Saint Louis University School Of Medicine in 1979. Dr. Bott-Silverman is a member of ACC.

Dr. Bott-Silverman is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.